|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating expenses | |||||
| Research and development expenses | |||||
| Selling, general and administrative expenses | |||||
| New warrants expenses | |||||
| Total operating expenses | |||||
| Operating loss | |||||
| Change in fair value of derivative liabilities | |||||
| Gain/(loss) from derivative liabilities | |||||
| Financial investment income | |||||
| Related party loan interest income | |||||
| Interest expense | |||||
| Other gain/(loss), net | |||||
| Loss before income taxes | |||||
| Income tax expense | |||||
| Net loss | |||||
| Total net loss | |||||
| Weighted-average number of shares outstanding – basic (in shares) | |||||
| Net loss per share – basic (in dollars per share) | |||||
Loading...